Staar Surgical price target lowered to $31 from $41 at Canaccord

Canaccord lowered the firm’s price target on Staar Surgical (STAA) to $31 from $41 and keeps a Hold rating on the shares. The firm said Management reiterated FY24 guidance, but with both China and the US businesses missing our estimates, and with management reducing the guidance related to both geographies, they remain cautious on the name.